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ABSTRACT
Objective: To assess measurement practice in clinical decision support evaluation studies.
Materials and Methods: We identified empirical studies evaluating clinical decision support systems published
from 1998 to 2017. We reviewed titles, abstracts, and full paper contents for evidence of attention to measure-
ment validity, reliability, or reuse. We used Friedman and Wyatt’s typology to categorize the studies.
Results: There were 391 studies that met the inclusion criteria. Study types in this cohort were primarily field
user effect studies (n¼210) or problem impact studies (n¼150). Of those, 280 studies (72%) had no evidence
of attention to measurement methodology, and 111 (28%) had some evidence with 33 (8%) offering validity evi-
dence; 45 (12%) offering reliability evidence; and 61 (16%) reporting measurement artefact reuse.
Discussion: Only 5 studies offered validity assessment within the study. Valid measures were predominantly
observed in problem impact studies with the majority of measures being clinical or patient reported outcomes
with validity measured elsewhere.
Conclusion: Measurement methodology is frequently ignored in empirical studies of clinical decision support
systems and particularly so in field user effect studies. Authors may in fact be attending to measurement
considerations and not reporting this or employing methods of unknown validity and reliability in their studies.
In the latter case, reported study results may be biased and effect sizes misleading. We argue that replication
studies to strengthen the evidence base require greater attention to measurement practice in health informatics
research.
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INTRODUCTION
Measurement is fundamental to empirical science and requires
instruments that are valid and reliable: that provide reproducible
results and measure what they claim to measure. For this reason,
researchers use preexisting measurement instruments wherever pos-
sible and typically only develop their own instruments when there is
no existing suitable instrument or when they are measuring a new
construct unaddressed in published research. Before using a new in-
strument, investigators should carry out measurement studies that
explore whether the methods are acceptably reliable and valid.1 If
these are absent, investigators must proceed carefully based only on
assumptions about what their measurements mean. Just as poor
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study design or inadequate sample size can jeopardize the integrity
of a study, so too can measurements that are to a significant extent
unreliable or invalid.2
It has been suggested that health informatics has a paucity of
well-known and consistently used research constructs with estab-
lished instruments for measuring them.3 A robust library of reusable
instruments creates an infrastructure for research that facilitates the
work of study design, strengthens the internal and external validity
of studies, and facilitates systematic reviews. Without this infra-
structure, the health informatics evidence base will be weak and
knowledge will not cumulate.4–6 In other disciplines such as the
behavioral sciences, there are bibliographic databases of measure-
ment instruments,7 and researchers are trained to use existing instru-
ments with known validity and reliability whenever possible.8
Previously validated instruments may require adaptation for
changed circumstances, but, whether utilizing an existing instrument
or developing a new one, explicit attention to measurement is im-
portant to the conduct and reporting of research.
Reliability and validity are core aspects of measurement.9 Car-
mines and Zeller define reliability as “the extent to which an experi-
ment, test, or any measuring procedure yields the same results on
repeated trials” and validity as the extent to which an indicator
“measures what it purports to measure.”10 An instrument can be re-
liable without being valid, but an instrument can only be valid if it is
first found to be reliable.2 Reliability assessment requires
readministration of the instrument on successive occasions or a
study of the internal consistency of independent observations within
a measurement process. There are differing approaches to validity
assessment but assessment of validity always requires use of external
standards. Face validity, a relatively weak indicator, employs subjec-
tive assessments by experts of whether a measure appears to include
all relevant facets of a construct and to measure what is intended.
Assessment of criterion–related validity requires 1 or more external
standards against which the measure should either be highly corre-
lated or not correlated. Assessment of construct validity is the stron-
gest approach but requires multiple additional constructs to be
assessed revealing a pattern of correlations with the measure from
which validity can be inferred.1 However, validity is not simply a
property of an instrument but arises from a combination of data col-
lected when the instrument is used in the context and with the popu-
lation for which it was intended.11
A previous review explored measurement practice in health in-
formatics studies employing quantitative methods.12 A significant
majority of those studies addressed clinical decision support systems,
examining 3 indicators of measurement practice: attention to the re-
liability of measures employed, the validity of those measures, and
reuse of pre-existing instruments. In that review, of the 27 studies
meeting the inclusion criteria, 3 reported reliability indices, and
8 suggested reuse of measurement methods, the majority of which
were reused within the same research group. None of the studies ex-
plicitly considered the validity of the measurements employed.
OBJECTIVE
This work extends the previous study12 by examining a significantly
larger body of articles using the same indicators of attention to
measurement with a specific focus on studies of clinical decision
support systems used by medically qualified practitioners (specifi-
cally, physicians or surgeons). While not providing an exact compar-
ison with the previous study, this review will help indicate whether
attention to measurement practice in health informatics has changed
over time. To provide a more detailed analysis, this paper describes
the spectrum of study types in the published literature using Fried-
man and Wyatt’s typology1 and examines the extent to which ex-
plicit attention to measurement is associated with the study type.
Related work13,14 has reported development of an inventory of
measurements applicable in health informatics but apparently with-
out quality assessment of attention to measurement practice.
This aim of this study is to address 3 research questions (RQs):
• RQ1 – What fraction of a cohort of studies of clinical decision
support systems (CDSS) used by medically qualified practitioners
have indicators of measurement reliability, validity, or reuse?
• RQ2 – What is the distribution of study types within this cohort?
• RQ3 – To what extent is attention to measurement reliability,
validity, or reuse related to study type?
MATERIALS AND METHODS
Search strategy
We identified a cohort of published studies and developed criteria to
assess the 3 categories of attention to measurement. We applied the
criteria to data extracted from each study to address RQ1. We cate-
gorized the specific study types to address RQ2. We examined the
association between study type and evidence of attention to mea-
surement to address RQ3, using the nonparametric Kruskal-Wallis
test in IBM SPSS version 25.
We first conducted a search to identify CDSS system evaluation
studies, using the PubMed database (given our focus on usage by
medically qualified practitioners). We selected articles written in En-
glish that had abstracts, were classified as clinical trials, and pub-
lished between January 1998 and December 2017. We limited our
search in this way based upon the fact that studies classed as clinical
trials would reasonably be assumed to be ones where mature mea-
surement practice might be found. The MeSH terms used in the pre-
vious study12 directed this search: medical records systems,
computerized; decision support systems, clinical; hospital informa-
tion systems; therapy, computer assisted; diagnosis, computer assis-
ted. Due to the high volume of results, we further restricted some
searches to MeSH major topics.15 To complement the MeSH search
strategy, we identified 3 seed papers16–18 from earlier work and con-
ducted a “snowball” search from their references.
Inclusion criteria
We manually filtered the search results based on title and abstract.
We included studies that examined CDSSs used by a medically qual-
ified practitioner, such as a physician or surgeon. Studies that stated
“clinician” use were included if it could be reasonably assumed that
clinician referred to a medically qualified practitioner. In this re-
view, CDSSs are defined as computer systems that utilize patient
data to provide timely patient-specific information or advice to sup-
port decision making.19 Example systems are computerized alerts or
reminders, computerized templates, order sets or clinical guidelines,
diagnostic support, and other relevant information supplied to the
physician to facilitate decision making.
We excluded studies about medical devices, decision aids used
by patients, telemedicine studies (unless a CDSS was involved),
study protocols, and systems used by health care professionals other
than medically qualified practitioners. Studies where only a minor
part of the intervention involved a CDSS were also excluded. Devel-
opmental IT system validation studies were also excluded.
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Criteria for attention to measurement
We based our general approach on the methods used in the previous
review, as we had the same aim to explore attention to reliability,
validity, or instrument reuse (RQ1).12 We defined reliability indica-
tors as the explicit report of any measure of reliability associated
with a method, measure, or instrument within the study or explicit
reference to separately published reliability indices. We defined va-
lidity indicators as reported validation methods within the study or
explicit reference to separately published validation methods. We
excluded studies that solely employed clinical and laboratory meas-
ures that might reasonably be presumed to be valid, but where the
paper did not otherwise demonstrate attention to measurement. We
defined reuse indicators as the presence of any statement in which a
study utilized a measurement instrument or method (in whole or in
part) derived from previous work, whether published or not, and re-
gardless of authorship.
Identifying and appraising the variables measured
We evaluated the measurement indicators in each study considering
both primary and secondary outcomes if they were explicitly stated
as such. Where this was not stated and it was unclear from the text,
we made an assessment of what measures to include from the study
objectives, data analysis, and results sections of the article. To en-
sure consistent data extraction and to calibrate our assessment, we
examined the reliability of our appraisal of measurement indicators
using Cohen’s kappa.20
Assessment of measurement indicators
We searched the manuscripts for measurement indicators by deter-
mining if they contained any keywords relating to validity and
reliability, namely: validity (construct, criterion, concurrent, predic-
tive, content, face, divergent, discriminant, convergent); reliability
(inter-rater/abstractor/coder, kappa, Cronbach’s alpha, Spearman-
Brown, test-retest reliability, and agreement); and synonyms, such
as accuracy and precision. Apart from a few papers that we had to
obtain as hard copies through inter-library loans, we executed this
as an electronic search of the full text.
As a formative exercise to calibrate our assessment of measure-
ment indicators, we calculated Cohen’s kappa20 from 50 randomly
selected studies independently reviewed by a second rater. Following
this calibration exercise, the bulk of the assessments were made in-
dependently by the 2 research assistants. The assessments were
reviewed by the lead author, but no further inter-rater reliability cal-
culation was made.
Study type categorization
After classifying studies according to evidence of measurement prac-
tice, we categorized them using Friedman and Wyatt’s typology1 to
assess whether measurement indicators were associated with specific
study types. This framework consists of 9 study types distinguished
on the basis of the aspect of the information system (“resource”)
studied, the study question, and the audience most interested in the
results (Table 1).
RESULTS
Literature review
Figure 1 summarizes the literature review process and results. The
initial corpus comprised 8780 articles. Title review and removal of
duplicates reduced the number of articles to 926. The first snowball
search based on seed papers resulted in 683 studies. The second
snowball search, based on 36 systematic reviews, retrieved a total of
812 papers. The 3 search strategies —the MeSH-driven search and
2 snowball searches—thus resulting in a total of 2421 papers.
Table 1. Classifications of generic study types by broad study questions and the stakeholders concerned,1 with kind permission from
Springer Science and Business Media.VC Springer Science and Business Media, Inc. 2006.
Study type Aspect studied Broad study question Audience/stakeholders primarily
interested in results
1 Needs assessment Need for the resource What is the problem? Resource developers, funders of the
resource
2 Design validation Design and development pro-
cess
Is the development method in accord
with accepted processes?
Funders of the resource; professional
and governmental certification
agencies
3 Structure validation Resource static structure Is the resource appropriately designed to
function as intended?
Professional indemnity insurers, resource
developers, professional and govern-
mental certification agencies
4 Usability test Resource dynamic usability
and function
Can intended users navigate the resource
so it carries out intended functions?
Resource developers, users
5 Laboratory function study Resource dynamic usability
and function
Does the resource have the potential to
be beneficial?
Resource developers, funders, users,
academic community
6 Field function study Resource dynamic usability
and function
Does the resource have the potential to
be beneficial in the real world
Resource developers, funders users
7 Laboratory user effect study Resource effect and impact Is the resource likely to change
behavior?
Resource developers and funders, users
8 Field user effect study Resource effect and impact Does the resource change user actual
user behavior in ways that are
positive?
Resource users and their clients, resource
purchasers and funders
9 Problem impact study Resource effect and impact Does the resource have a positive impact
on the original problem?
The universe of stakeholders
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The studies were then limited to decision support systems used by
medically qualified practitioners, which excluded 1933 papers and
left 488 in the corpus. Deduplication and further review of abstracts
reduced the corpus to 391 studies. The large number of studies ex-
cluded for not meeting the intended user criteria was due to
abstracts that failed to identify users of the system.
Reliability of the assessment of measurement
indicators
The result of the formative inter-rater reliability assessment
(j¼0.34) is conventionally interpreted as “fair agreement,” but
showed room for improvement given that j¼0.41–0.60 is consid-
ered “moderate agreement.”20 We then reviewed how we were
Figure 1. Literature review process and results.
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applying the criteria and explored the reasons for differing assess-
ments. Following this calibration process, we reached agreement for
all 50 studies in the sample set and the rest of the appraisals were
made independently by the 2 research assistants (AB, TA).
Research question 1: indicators of measurement
reliability, validity or reuse
We found measurement indicators in 111/391 studies (28%) listed
in the supplementary file. It was also found that 45/391 (12%) had
reliability indicators, 33/391 (8%) had validity indicators, and 61/
391 (16%) had reuse indicators. These categorizations were not mu-
tually exclusive, as shown in Figure 2. In 280/391 studies (72%) no
evidence of measurement indicators was found.
Reliability
We found reliability indicators in 45 studies (12%). Evidence
primarily comprised reported measurement of chance-corrected
inter-rater agreement/reliability (Cohen’s kappa) for the abstraction
of data from medical records to facilitate measurement (eg, identify-
ing the documentation of certain items, whether a particular test or
adverse event had occurred, or for categorization purposes). A small
number of studies measured inter-rater agreement with a percentage
or employed other measures of reliability such as test-retest, intra-
class correlation coefficient, Cronbach’s alpha, or claimed reliability
with no measurement given as shown in Table 2. The total number
of instances is 50, as some studies reported more than 1 reliability
measure.
Validity
From the 33 studies (8%) with validity indicators, we identified 68
distinct measurements. Of these, 63 had validity measured else-
where, and 5 had validity measured within the study.
Most of the measures that had validity evidence that were pa-
tient health outcomes or process of care measures; only 6 were not:
• a continuous diagnostic quality scorea,21 where validity had been
assessed in a previous study;
• a composite quality score calculated for diagnostic and manage-
ment plansb,22 which carried out a thorough validity and reliabil-
ity assessment within the study;
• a known usability measure: the Standard Usability Scorec was
used by 2 studies23,24;
• a survey measuring house staff attitudes toward CPOEd which
had been face validated25;
• the semantic differential power perception surveye which had
also been shown to be valid in a previous study.26
Table 3 shows the categorization by measurement domain, with
the alphabetic superscripts referencing the 6 measures listed
previously.
Reuse
We found reuse of 68 measurement artefacts from 61 studies (some
studies reused more than 1 artefact, others reused the same artefact).
The majority of reused artefacts were modified instruments (n¼13).
Of the reused instruments, 4 had evidence of reliability. A number
of established methods for identifying and classifying adverse drug
events were identified, most of which were internally reused by the
same research group. A number of studies showed evidence of reuse
of other artefacts as shown in Table 4.
Figure 2.Measurement indicators in all included studies.
Table 2. Reliability indicators
Studies with Reliability Indicators
Indicator Instances
Inter-rater Cohen’s kappa 28
Inter-rater percentage 8
Test-retest 1
Intraclass correlation coefficient 2
Cronbach’s alpha 5
Claimed (no measurement specified)
TOTAL
6
50
Table 3. Valid measures by domain
Primary Category User Measures Patient Health Process of Care IT System
Secondary Category Physician
Knowledge,
attitudes, or beliefs.
Physician decisions
or diagnostic/
therapeutic accuracy
Physician
satisfaction
or perceptions
Laboratory Clinical
Measure or
Outcome
Patient
Reported
Outcome
Patient
Safety
Patient
Reported
Experience
Usability/
usefulness
Total
Validity
Measured
Elsewhere
1a 1e 15 30 4 10 2c 63
Validity
Measured
in Study
2d 1b 1 1 5
Total 2 2 1 0 15 31 4 10 3 68
a-eMeasures that were not categorized as patient health outcomes or process of care measures.
Journal of the American Medical Informatics Association, 2019, Vol. 0, No. 0 5
D
ow
nloaded from
 https://academ
ic.oup.com
/jam
ia/advance-article-abstract/doi/10.1093/jam
ia/ocz035/5470864 by U
niversity of Portsm
outh Library user on 29 April 2019
Research question 2 – categorization of study types
Using the typology, 6 types were identified in the cohort1: studies of
usability, laboratory user effect, laboratory function, field function,
field user effect, and problem impact. Figure 3 shows the study type
distribution for the 391 included studies. Studies identified were pre-
dominantly field user effect and problem impact studies.
Research question 3: relationship of study type with
measurement indicators
Figure 4 shows the distribution of study types by measurement indi-
cators. The percentage is the proportion of studies with that indica-
tor (or the absence of indicators).
Most studies were problem impact studies or field user effect
studies. The Kruskal-Wallis test showed a significant association
between study type and the presence of validity indicators (P ¼
.007) and a significant association with the absence of mature
measurement indicators (P ¼ .005) but no significant association
with reliability or reuse indicators. We interpret this to suggest a
bi-modal distribution: while the majority of studies have no mea-
surement indicators, there is a significant minority (mostly prob-
lem impact studies) that do address validity. Of course, there is an
inherent bias in our sample: the predominant study types in the
cohort reflect our decision to exclude developmental system vali-
dation studies.
DISCUSSION
We set out to answer 3 research questions on measurement practice
in health informatics studies, focusing on CDSS evaluation. We
found that 28% (111/391) of the eligible studies had some evidence
of at least 1 of the 3 defined measurement indicators. Assessment of
reliability was identified in 12% (45/391) of studies. However, the
majority of these measurements did not directly assess the reliability
of an instrument or measure, but demonstrated the reliability of
data abstraction from medical records to facilitate measurement.
Validity evidence was identified in 8% (33/391) of studies, com-
prising 68 individual measures. However, the majority of valid
measures (93%, 63/68) had no direct evidence of validity assessment
indicated in the study. Only 5 studies (7%, 5/68) had evidence of di-
rect measurement of validity.
Reuse of measurement artefacts was identified in 16% (61/391)
of studies. The majority of these either modified previously valid
instruments or reused instruments and methods where there was no
indication of validity. Of these studies 38% (23/61) referenced addi-
tional measurement data such as reliability or validity. In the major-
ity of studies in our cohort where an instrument had been modified,
no evidence of the validity or reliability of the ‘new’ instrument was
provided.
A direct comparison with the previous study of measurement
practice in health informatics12 cannot be made due to the different
inclusion criteria and categorizations. However, this review echoes
the earlier conclusion that measurement practice is immature in the
field of health informatics. Our study included 18 of the 27 studies
in the earlier review. Of the 9 not included, 5 were outside the de-
fined date range and 4 did not meet our inclusion criteria. Identifica-
tion and categorization differed in 8 studies due to the modified
criteria for the measurement indicators.
Table 4. Reuse indicators
Studies with Reuse Indicators
Reuse Artefact No of Studies
Modified or un-validated instrument 23
Methodology (all or part) 17
Measurement 6
Categorization 8
Guideline/protocol 3
Criteria 8
Definition 3
TOTAL 68
Figure 3. Distribution of study types (all included studies n¼391).
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RQ2 addressed the prevalence of different study types in our
study cohort. The study type analysis revealed that 54% (210/391)
of the studies were field user effect studies and 38% (150/391) were
problem impact studies. RQ3 addressed the relationship between
study type and evidence of any of the 3 measurement indicators.
There was a significant association between study type and validity
indicators, but also between study type and absence of measurement
indicators. Only 3% (7/210) of field user effect studies had validity
indicators and only 14% (21/33) of problem impact studies.
In the 280 studies with no evidence of measurement practice, the
most prevalent measures were behavioral, such as compliance mea-
sured using objective counts (eg, the number of compliant prescrip-
tions). Even though these measures might be assumed to be perfectly
reliable since they are “counts,” the subjective construct of
“compliance” raises the distinct possibility that multiple assessors
of compliance might not agree. Further investigation of this type of
measure needs to be undertaken to assess how and whether sources
of error are being quantified and if more attention to good measure-
ment practice is required in studies that employ these measures. The
absence of good measurement practice does cast doubt on the extent
to which the measured outcome is a true reflection of reality. The
previous review12 also stated that the measurement aspects of stud-
ies should be separate from the demonstration aspects in order for
researchers to benefit from utilizing each other’s measurement tools.
Studies may not report reliability and validity measurements if
researchers regard an instrument as well-known and authoritative
(eg, established clinical scales). This is acceptable if the instrument is
being used under the same conditions for which reliability and valid-
ity have previously been assessed; however, this should be clearly
stated in the article. It is also necessary to account for attenuation,
which will make measured effect sizes smaller than actual effect sizes
due to measurement error.
It is immensely challenging to evaluate a unique health informat-
ics system situated in an already complex environment that involves
numerous variables.27 However, unless our field begins to develop a
range of valid well-understood measures, the evidence base will re-
main weak and incomplete. This methodological weakness is not
unique to health informatics but appears to be common in other
areas of health care evaluation.28 Significant activities have been
undertaken to work toward the goal of evidence-based health
informatics,29 however there is still progress to be made.
One of the difficulties we found was the varied and sometimes
unclear reporting styles and language used when trying to de-
scribe measurement methods, identify evidence, and categorize
studies. The European Federation for Medical Informatics
guideline for Good Evaluation Practice in Health Informatics30
and the associated Statement of Reporting of Evaluation Studies
in Health Informatics31,32 provide clear guidance on how to
plan, perform, and publish a methodologically sound evaluation
study, which includes explicit recommendations about attention
to measurement issues. These resources can be combined with
other standards such as the Consolidated Standards of Reporting
Trials.33 Comprehensive textbooks on health informatics evalua-
tion and handbooks of methods exist to assist researchers to se-
lect the most appropriate methodology for the study being
undertaken and explain the issues of measurement practice in
detail.1,34,35 Databases of measures exist for health care, such as
the National Quality Measures Clearinghouse.36 The Agency for
Healthcare Research and Quality has published a small collection
of health informatics evaluation measures,37 and initiatives
such as the Core Outcome Measures in Effectiveness Trials aim
to establish agreed standardized sets of outcome measures.6
These works have assisted in moving toward evidence-based
health informatics.
Figure 4. Distribution of study types by measurement indicators.
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Further work
An extension to this review could be the development of a database
of measures for health informatics researchers, which would cover
not only patient outcome or process of care measures but user, fi-
nancial, system, and other aspects. Some work in this area has begun
with a project to identify and evaluate measures for patient-facing
technologies.38 A further consideration is to identify and describe
the theoretical foundations of validated measures.13
Limitations
This review is potentially limited by the use of only 1 database
(PubMed). Given the defined scope, we did not search nursing bib-
liographic databases as studies were only included if used by a medi-
cally qualified practitioner. A previous systematic review of clinical
decision support interventions that searched a number of databases
found that all the studies included in the final study sample were
also indexed and available in MEDLINE. Therefore, we also believe
this limitation to be negligible.39 However, we acknowledge that the
selection of PubMed using the methodology employed here may not
be completely reproducible over time.
A further limitation is that single researchers independently car-
ried out the initial study selection, evidence assessment, and
categorization process; however, formative inter-rater reliability as-
sessment was carried out to mitigate this. We did not compare the
distribution of study types in the inter-rater sample with the full set
of papers, so there is a risk that the inter-rater reliability assessment
was biased by an unrepresentative subset of studies.
This review has only looked at CDSS interventions; it is possible
that other health informatics studies may demonstrate attention to
measurement practice not identified here. The purpose of this review
was purely to identify evidence—not to assess the quality of the evi-
dence. It was also not our intention to assess the quality of the stud-
ies overall or to question the methodologies employed. Studies often
do not clearly state who an intervention is used by, which can be
problematic for non-medical researchers, and, in some cases, evi-
dence is not clear and could be misinterpreted. We acknowledge
that researchers may have carried out reliability or validity measure-
ment but not reported this in their article.
CONCLUSION
We do not question that holistic evaluation requires mixed methods
and a range of epistemological perspectives,40,41 and that qualitative
studies play an important role in addressing the why and how of
health informatics interventions. However, we maintain that, as a
basic scientific principle, any evaluation that reports quantitative
results should give due consideration to sound measurement. This
should be taken into account when designing the study, so that the
evaluation is scoped and resourced as necessary to deliver robust
results. Given suitable reuse, not every evaluation will need its own
measurement study; but the limitations imposed by using any
untested measures should always be acknowledged.
We argue that this review of outcomes in CDSS evaluation stud-
ies shows that attention to measurement practice remains weak.
This review has also highlighted the prevalence of field user effect
studies utilizing behavioral measures with little discussion of valid-
ity. We echo the recent call from Coiera and colleagues6 to take seri-
ously the scientific challenge facing our discipline: evidence-based
health informatics requires replication studies to strengthen or
question previous findings. This requires a toolset of validated and
reliable measurement instruments.
We call on leaders in the health informatics field, researchers
and funders, educators, professional bodies, and journal editors and
referees to promote the practice of undertaking and reporting mea-
surement studies in health informatics evaluation.
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